| MeSH term | MeSH ID | Detail |
|---|---|---|
| Tick Bites | D064927 | 1 associated lipids |
| Chlamydial Pneumonia | D061387 | 2 associated lipids |
| Reproductive Tract Infections | D060737 | 1 associated lipids |
| Granulomatous Mastitis | D058890 | 1 associated lipids |
| Trichiasis | D058457 | 1 associated lipids |
| Asymptomatic Infections | D058345 | 1 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Neglected Diseases | D058069 | 3 associated lipids |
| Corneal Endothelial Cell Loss | D055954 | 1 associated lipids |
| Multiple Pulmonary Nodules | D055613 | 2 associated lipids |
| Acute Lung Injury | D055371 | 33 associated lipids |
| Failed Back Surgery Syndrome | D055111 | 3 associated lipids |
| Tracheobronchomalacia | D055089 | 1 associated lipids |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | D054198 | 10 associated lipids |
| Hyper-IgM Immunodeficiency Syndrome | D053306 | 1 associated lipids |
| Pyomyositis | D052880 | 2 associated lipids |
| Male Urogenital Diseases | D052801 | 1 associated lipids |
| Tendinopathy | D052256 | 3 associated lipids |
| Mucositis | D052016 | 7 associated lipids |
| Pyloric Stenosis, Hypertrophic | D046248 | 2 associated lipids |
| Moraxellaceae Infections | D045828 | 3 associated lipids |
| Desulfovibrionaceae Infections | D045824 | 5 associated lipids |
| Pulmonary Disease, Chronic Obstructive | D029424 | 16 associated lipids |
| Chlamydophila Infections | D023521 | 4 associated lipids |
| Communicable Diseases, Emerging | D021821 | 3 associated lipids |
| Central Nervous System Protozoal Infections | D020808 | 3 associated lipids |
| Multiple Sclerosis, Relapsing-Remitting | D020529 | 7 associated lipids |
| Focal Nodular Hyperplasia | D020518 | 1 associated lipids |
| Neurotoxicity Syndromes | D020258 | 34 associated lipids |
| Acquired Hyperostosis Syndrome | D020083 | 1 associated lipids |
| Syncope, Vasovagal | D019462 | 1 associated lipids |
| Pouchitis | D019449 | 3 associated lipids |
| Pseudolymphoma | D019310 | 1 associated lipids |
| Gingival Overgrowth | D019214 | 7 associated lipids |
| Abdominal Abscess | D018784 | 2 associated lipids |
| Parasitemia | D018512 | 5 associated lipids |
| Pneumonia, Bacterial | D018410 | 16 associated lipids |
| T-Lymphocytopenia, Idiopathic CD4-Positive | D018344 | 1 associated lipids |
| Furcation Defects | D017823 | 1 associated lipids |
| Granuloma, Pyogenic | D017789 | 2 associated lipids |
| Community-Acquired Infections | D017714 | 8 associated lipids |
| Pelvic Pain | D017699 | 7 associated lipids |
| Aortic Aneurysm, Abdominal | D017544 | 5 associated lipids |
| Pityriasis Rosea | D017515 | 3 associated lipids |
| Skin Diseases, Bacterial | D017192 | 8 associated lipids |
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
| Common Variable Immunodeficiency | D017074 | 4 associated lipids |
| Gram-Negative Bacterial Infections | D016905 | 16 associated lipids |
| Neisseriaceae Infections | D016870 | 3 associated lipids |
| Ureaplasma Infections | D016869 | 5 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Infection fighters. MAC prevention takes a holiday. | 2000 | TreatmentUpdate | pmid:12132450 | |
| Noedl H | ABC - antibiotics-based combinations for the treatment of severe malaria? | 2009 | Trends Parasitol. | pmid:19819757 |
| Chang AB et al. | Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial. | 2012 | Trials | pmid:22937736 |
| Pokharel S et al. | Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial. | 2017 | Trials | pmid:28969659 |
| Uzun S et al. | Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial. | 2012 | Trials | pmid:22682323 |
| Chang AB et al. | Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. | 2013 | Trials | pmid:23421781 |
| Chang AB et al. | Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol. | 2011 | Trials | pmid:21492416 |
| Brittain C et al. | Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial. | 2016 | Trials | pmid:27881151 |
| Bandyopadhyay R et al. | Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. | 2018 | Trop Doct | pmid:29495943 |
| Rajapakse S et al. | Drug treatment of scrub typhus. | 2011 | Trop Doct | pmid:21172901 |
| Fegan D et al. | Resurgence of yaws in Tanna, Vanuatu: time for a new approach? | 2010 | Trop Doct | pmid:20305095 |
| Mahajan SK et al. | Scrub typhus and malaria co-infection causing severe sepsis. | 2014 | Trop Doct | pmid:24249027 |
| Fegan D et al. | Tropical leg ulcers in children: more than yaws. | 2016 | Trop Doct | pmid:26289420 |
| Lubell Y et al. | Susceptibility of bacterial isolates from community-acquired infections in sub-Saharan Africa and Asia to macrolide antibiotics. | 2011 | Trop. Med. Int. Health | pmid:21740488 |
| Kuper H et al. | Participatory evaluations of trachoma control programmes in eight countries. | 2005 | Trop. Med. Int. Health | pmid:16045463 |
| Keenan JD et al. | Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected? | 2012 | Trop. Med. Int. Health | pmid:22122734 |
| Edwards T et al. | Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin. | 2008 | Trop. Med. Int. Health | pmid:18282237 |
| Luntamo M et al. | The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial. | 2013 | Trop. Med. Int. Health | pmid:23432801 |
| Chico RM and Chandramohan D | Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy. | 2011 | Trop. Med. Int. Health | pmid:21477099 |
| de Vries PI et al. | Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence. | 1999 | Trop. Med. Int. Health | pmid:10402979 |